title: WITHDRAWN: Immunotherapy for advanced renal cell cancer.
authors.affiliation: Medical Oncology, BC Cancer Agency Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC, Canada, V8R 6V5.
authors.forename: Chris
authors.initials: C
authors.lastname: Coppin
authors.forename: Franz
authors.initials: F
authors.lastname: Porzsolt
authors.forename: Michael
authors.initials: M
authors.lastname: Autenrieth
authors.forename: Julia
authors.initials: J
authors.lastname: Kumpf
authors.forename: Andrew
authors.initials: A
authors.lastname: Coldman
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Wilt
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D016898:Interferon-alpha; D007376:Interleukin-2; D000068258:Bevacizumab